NSE · MANIPALHOS.NS
Manipal Health Enterprises Limited
₹650.55+₹11.75 (+1.84%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
Loading market information…
NSE · YATHARTH.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:13 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Yatharth Hospital & Trauma Care Services Limited’s quoted price sits in the upper half of its reported 52-week range, 21.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Yatharth Hospital & Trauma Care Services Limited’s next earnings report is currently expected on Nov 3, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Yatharth Hospital & Trauma Care Services Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2008 and headquartered in Noida, India, Yatharth Hospital & Trauma Care Services Limited operates and manages super-specialty medical facilities across Delhi and Madhya Pradesh. These hospitals offer an extensive range of healthcare services. Core specializations include women's health (gynecology), digestive medicine (gastroenterology), respiratory conditions (pulmonology), pediatrics, kidney and urinary tract care (nephrology and urology), cardiology, orthopedics, spine and rheumatology, and neurosciences. Additionally, the company provides general medicine, surgery, ENT, physiotherapy, rehabilitation, interventional spine and pain medicine, nutrition, pathology, laboratory diagnostics, dentistry, ophthalmology, dermatology, anesthesiology, radiology, and psychology and psychiatry.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:16 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ₹4.00+2.56% vs estimate |
| ₹2.32B-1.65% vs estimate |
| Q3 2025 | Jan 27, 2025 | ₹3.60+5.88% vs estimate | ₹2.19B+6.64% vs estimate |
|---|
| Q2 2025 | Nov 7, 2024 | ₹3.60 | ₹2.18B-4.43% vs estimate |
|---|
KEEP COMPARING
₹650.55+₹11.75 (+1.84%)
Manipal Health Enterprises Limited’s quoted price sits in the lower half of its reported 52-week range, 20.17% below the high.
₹854.15+₹3.00 (+0.35%)
Max Healthcare Institute Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.17% below the high.
₹751.35-₹3.55 (-0.47%)
Fortis Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 28.97% below the high.
₹1,725.20+₹10.70 (+0.62%)
Narayana Hrudayalaya Limited’s quoted price sits in the lower half of its reported 52-week range, 17.51% below the high.
₹1,301.30+₹1.60 (+0.12%)
Global Health Limited’s quoted price sits in the upper half of its reported 52-week range, 15.71% below the high.
₹700.95-₹1.55 (-0.22%)
Krishna Institute of Medical Sciences Limited’s quoted price sits in the lower half of its reported 52-week range, 18.27% below the high.
₹258.10-₹2.00 (-0.77%)
Jupiter Life Line Hospitals Limited’s quoted price sits in the lower half of its reported 52-week range, 23.94% below the high.
₹5,791.00-₹105.00 (-1.78%)
Kovai Medical Center and Hospital Limited’s quoted price sits in the upper half of its reported 52-week range, 10.13% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
